Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Nephros (NEPH) Current Leases (2019 - 2020)

Nephros has reported Current Leases over the past 2 years, most recently at $332000.0 for Q4 2020.

Quarterly results put Current Leases at $332000.0 for Q4 2020, up 26.72% from a year ago — trailing twelve months through Dec 2020 was $332000.0 (up 26.72% YoY), and the annual figure for FY2020 was $332000.0, up 26.72%.
Current Leases for Q4 2020 was $332000.0 at Nephros, up from $326000.0 in the prior quarter.
Over the last five years, Current Leases for NEPH hit a ceiling of $332000.0 in Q4 2020 and a floor of $191000.0 in Q1 2019.